Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05004857 · ClinicalTrials.gov registry record · NA
The Effect of Reading Therapy on Newborns
A NA study of Autonomic Nervous System Diseases, sponsored by Tulane University.
- Active
- Registry status
- NA
- Development phase
- 1
- Enrollment target
- 1
- Study location
NCT05004857: Active NA study of Autonomic Nervous System Diseases, sponsored by Tulane University.
NCT05004857 is a NA study of Autonomic Nervous System Diseases that is active but no longer recruiting, run by Tulane University. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05004857, a NA study of Autonomic Nervous System Diseases, is active but no longer recruiting, sponsored by Tulane University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this pilot study is to specifically examine the effect of parental reading on the ANS of mother and neonate in the hospital setting. The investigators will examine the effect of live maternal-infant reading on typically developing infants to better understand the physiological benefits of live reading on newborns.
Primary Outcome
The change in vagal tone from the reading therapy will be measured using MindWare System, where an increase in vagal tone shows positive physiological outcomes in the newborns and mothers.
Conditions Studied
Interventions
- BEHAVIORAL Book reading
Study Locations (1)
Louisiana
- Tulane University Health Sciences Center - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2021-09-17 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT05004857 still lists
NCT05004857 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Autonomic Nervous System Diseases appearing as the primary indexed condition, and to 1 intervention - of which Book reading is the first listed.
NCT05004857 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT05004857 about?
NCT05004857 is a clinical study titled "The Effect of Reading Therapy on Newborns". The primary purpose of this pilot study is to specifically examine the effect of parental reading on the ANS of mother and neonate in the hospital setting. The investigators will examine the effect of live maternal-infant reading on typically developing infants to better understand the physiological...
What is the current status of trial NCT05004857?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1 participants. The study started on 2021-09-17. Estimated completion is 2026-12.
What conditions does trial NCT05004857 study?
This clinical trial studies the following conditions: Autonomic Nervous System Diseases.
What interventions are being tested in trial NCT05004857?
The interventions under investigation include: Book reading (BEHAVIORAL).
Who is sponsoring clinical trial NCT05004857?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05004857 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autonomic Nervous System Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05004857's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI